Evidence map›Paper›PMID 26590118›Full record

ArticleCancer medicine2016

Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis.

Fiona M Frame, Huguette Savoie, Francesca Bryden, Francesca Giuntini, Vincent M Mann, Matthew S Simms, Ross W Boyle, Norman J Maitland

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Effect of intermittency factor on singlet oxygen and PGEBiochemistry and biophysics reports · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Fiona M FrameYCR Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, United Kingdom.
Huguette SavoieDepartment of Chemistry, University of Hull, Kingston Upon Hull, HU6 7RX, United Kingdom.
Francesca BrydenDepartment of Chemistry, University of Hull, Kingston Upon Hull, HU6 7RX, United Kingdom.
Francesca GiuntiniSchool of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Liverpool, L3 2AJ, United Kingdom.
Vincent M MannDepartment of Urology, Castle Hill Hospital (Hull and East Yorkshire Hospitals NHS Trust), Cottingham, HU16 5JQ, United Kingdom.
Matthew S SimmsDepartment of Urology, Castle Hill Hospital (Hull and East Yorkshire Hospitals NHS Trust), Cottingham, HU16 5JQ, United Kingdom.
Ross W BoyleDepartment of Chemistry, University of Hull, Kingston Upon Hull, HU6 7RX, United Kingdom.
Norman J MaitlandYCR Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, United Kingdom.
University of Hull · GBHull York Medical School · GBLiverpool John Moores University · GBUniversity of York · GBYorkshire Cancer Research · GB

Funding

Yorkshire Cancer Research Y257PA
6 · The paper itself

Abstract

In comparison to more differentiated cells, prostate cancer stem-like cells are radioresistant, which could explain radio-recurrent prostate cancer. Improvement of radiotherapeutic efficacy may therefore require combination therapy. We have investigated the consequences of treating primary prostate epithelial cells with gamma irradiation and photodynamic therapy (PDT), both of which act through production of reactive oxygen species (ROS). Primary prostate epithelial cells were cultured from patient samples of benign prostatic hyperplasia and prostate cancer prior to treatment with PDT or gamma irradiation. Cell viability was measured using MTT and alamar blue assay, and cell recovery by colony-forming assays. Immunofluorescence of gamma-H2AX foci was used to quantify DNA damage, and autophagy and apoptosis were assessed using Western blots. Necrosis and senescence were measured by propidium iodide staining and beta-galactosidase staining, respectively. Both PDT and gamma irradiation reduced the colony-forming ability of primary prostate epithelial cells. PDT reduced the viability of all types of cells in the cultures, including stem-like cells and more differentiated cells. PDT induced necrosis and autophagy, whereas gamma irradiation induced senescence, but neither treatment induced apoptosis. PDT and gamma irradiation therefore inhibit cell growth by different mechanisms. We suggest these treatments would be suitable for use in combination as sequential treatments against prostate cancer.

Indexed as

Gamma RaysApoptosisAutophagyCell ProliferationCells, CulturedCell SurvivalCellular SenescenceDNA DamageEpithelial CellsHumansMaleOxidative StressPhotochemotherapyPhotosensitizing AgentsProstateProstatic NeoplasmsPhotosensitizing AgentsReactive Oxygen SpeciesCancer stem-like cellsphotodynamic therapyprostate cancerradiotherapy

Identifiers

PMID26590118
PMCPMC4708897
OpenAlexW2173482532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.